new Delhi: Dr. Randeep Guleria, Director of All India Institute of Medical Sciences (AIIMS) and one of the leading medical experts of India has claimed that cases of coronavirus in the country have not reached their peak yet. This comment has come at a time when at least one lakh new infection cases are being added every two days in the country. Since the first case surfaced on January 30, more than 23 lakh cases have been registered so far. So far more than 46,000 people have lost their lives due to infection. Also Read – Corona havoc in Lucknow, 831 new corona patients found in one day, doctors expressed concern
Dr. Guleria, director of AIIMS, is also part of a core team monitoring the epidemic. He said that it is time to take the test, but the infection has not yet reached its peak in India. Regarding the development of the vaccine, he said that India will benefit greatly from it, because it makes about 60 percent of the world’s vaccines or vaccines. Also Read – Corona havoc continues in Maharashtra, 11088 new cases were reported in 24 hours, 256 died
He said, “We have the capacity to produce a large number of vaccines and the commitment shown by the government and manufacturers is that we will be able to build our manufacturing capacity not only for our country but for the whole world.” Three vaccine candidates in India are in various stages of human clinical trials. The first is being tested by Serum Institute of India and Oxford University, Pune, second by Bharat Biotech and third by Zydus Cadila. Also Read – Nepal reduced the entry point for Indian nationals from 20 to half, increased the ban on flights
The country’s top pulmonologist said that the process of making the vaccine has progressed so fast due to the collaborative work between different countries. Guleria said that the epidemic has forced researchers, manufacturers and industry to come together to overcome any difficulty we face.
Guleria, however, advised caution with regard to the Russian vaccine, which is being called the world’s first coronavirus vaccine. He said about the safety aspect that the issue will be only to ensure that the vaccine is safe and effective. Guleria said, “Any vaccine that is tried on a large number of people who are elderly or who already have the disease, then safety is the most important thing.” Let me tell you that recently Russian President Vladimir Putin has announced that Russia has made a vaccine of Coronavirus, after which this comment of Guleria has come.